Related references
Note: Only part of the references are listed.β-Klotho gene variation is associated with liver damage in children with NAFLD
Paola Dongiovanni et al.
JOURNAL OF HEPATOLOGY (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients
Paola Dongiovanni et al.
JOURNAL OF LIPID RESEARCH (2019)
KLB gene polymorphism is associated with obesity and non-alcoholic fatty liver disease in the Han Chinese
Fang Ji et al.
AGING-US (2019)
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
Na Jiao et al.
GUT (2018)
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
Puneet Puri et al.
HEPATOLOGY (2018)
Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells
Oriana Lo Re et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
beta-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in mice
Emmanuel Somm et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)
Mass spectrometric analysis of the N-glycoproteome in statin-treated liver cells with two lectin-independent chemical enrichment methods
Haopeng Xiao et al.
INTERNATIONAL JOURNAL OF MASS SPECTROMETRY (2018)
Disruption of TFGβ-SIVIAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand
Adriana Carino et al.
PHARMACOLOGICAL RESEARCH (2018)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue
Kathleen R. Markan et al.
MOLECULAR METABOLISM (2017)
FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss
Javier Gomez-Ambrosi et al.
CLINICAL NUTRITION (2017)
Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease
Valerio Nobili et al.
GASTROENTEROLOGY (2016)
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
Rosellina Margherita Mancina et al.
GASTROENTEROLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Pathobiology of liver fibrosis: a translational success story
Youngmin A. Lee et al.
GUT (2015)
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease
Paola Dongiovanni et al.
HEPATOLOGY (2015)
Statin use and non-alcoholic steatohepatitis in at risk individuals
Paola Dongiovanni et al.
JOURNAL OF HEPATOLOGY (2015)
Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease
Joerg Jahnel et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2015)
Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases
Fangfang Zhang et al.
MOLECULAR ENDOCRINOLOGY (2015)
Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21
Bryn M. Owen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Effects of N-glycosylation on protein conformation and dynamics: Protein Data Bank analysis and molecular dynamics simulation study
Hui Sun Lee et al.
SCIENTIFIC REPORTS (2015)
Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients
J. M. Gallego-Escuredo et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors
Paola Dongiovanni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
Ffolliott M. Fisher et al.
DIABETES (2010)
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Jody Dushay et al.
GASTROENTEROLOGY (2010)
I148M Patatin-Like Phospholipase Domain-Containing 3 Gene Variant and Severity of Pediatric Nonalcoholic Fatty Liver Disease
Luca Valenti et al.
HEPATOLOGY (2010)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
Share Paper
